Request Sample Inquiry
Neurodiagnostics Market

Neurodiagnostics Market

Neurodiagnostics Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

210

Base Year:

2024

Date

Dec - 2024

Format:

PDF XLS PPT

Report Code:

VMR-3681

Segments Covered
  • By Product By Product Diagnostic and Imaging Systems, Electroencephalogram (EEG) Systems, Electromyography (EMG) Products, Magnetic Resonance Imaging (MRI) Systems, Ultrasound Imaging Systems, Computed Tomography (Ct) Scanner, Magnetoencephalogram (Meg) System, Position Emission Tomography (Pet) System, Angiography System, Other Systems, Clinical Testing Instruments, PCR, Next-Generation Sequencing (NGS), Sanger Sequencing, Other Clinical Diagnostic Products, Reagents & Consumables, Media and Serra, Solvents, Enzymes, Protein & Peptides, Probes, Buffers, Antibodies, Other Reagents
  • By Condition By Condition Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, Other Diseases
  • By End User By End User Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2024
Forecast YearsForecast Years: 2025 - 2034
Historical YearsHistorical Years: 2019 - 2023
Revenue 2024Revenue 2024: USD XX Billion
Revenue 2034Revenue 2034: USD XX Billion
Revenue CAGRRevenue CAGR (2025 - 2034): 7.4%
Fastest Growing Region Fastest Growing Region (2025 - 2034) North America
Largest Region Largest Region (2024): XX
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Neurodiagnostics Market - Segment Analysis
    1. Overview
    2. Global Neurodiagnostics Market, 2016 - 2028 (USD Million)
    3. Global Neurodiagnostics Market - by Product
      1. By Diagnostic and Imaging Systems
      2. By Electroencephalogram (EEG) Systems
      3. By Electromyography (EMG) Products
      4. By Magnetic Resonance Imaging (MRI) Systems
      5. By Ultrasound Imaging Systems
      6. By Computed Tomography (Ct) Scanner
      7. By Magnetoencephalogram (Meg) System
      8. By Position Emission Tomography (Pet) System
      9. By Angiography System
      10. By Other Systems
      11. By Clinical Testing Instruments
      12. By PCR
      13. By Next-Generation Sequencing (NGS)
      14. By Sanger Sequencing
      15. By Other Clinical Diagnostic Products
      16. By Reagents & Consumables
      17. By Media and Serra
      18. By Solvents
      19. By Enzymes, Protein & Peptides
      20. By Probes
      21. By Buffers
      22. By Antibodies
      23. By Other Reagents
    4. Global Neurodiagnostics Market - by Condition
      1. By Neuro Degenerative Diseases
      2. By Epilepsy
      3. By Stroke
      4. By Headache Disorders
      5. By Sleep Disorders
      6. By Other Diseases
    5. Global Neurodiagnostics Market - by End User
      1. By Hospitals and Surgery Centers
      2. By Neurology Centers
      3. By Ambulatory Care Centers
      4. By Diagnostic Laboratories & Imaging Centers
      5. By Research Laboratories & Academic Institutes
    6. Global Neurodiagnostics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Neurodiagnostics Market - Segment Analysis
    1. Overview
    2. North America Neurodiagnostics Market, 2016 - 2028 (USD Million)
    3. North America Neurodiagnostics Market, by Product
      1. By Diagnostic and Imaging Systems
      2. By Electroencephalogram (EEG) Systems
      3. By Electromyography (EMG) Products
      4. By Magnetic Resonance Imaging (MRI) Systems
      5. By Ultrasound Imaging Systems
      6. By Computed Tomography (Ct) Scanner
      7. By Magnetoencephalogram (Meg) System
      8. By Position Emission Tomography (Pet) System
      9. By Angiography System
      10. By Other Systems
      11. By Clinical Testing Instruments
      12. By PCR
      13. By Next-Generation Sequencing (NGS)
      14. By Sanger Sequencing
      15. By Other Clinical Diagnostic Products
      16. By Reagents & Consumables
      17. By Media and Serra
      18. By Solvents
      19. By Enzymes, Protein & Peptides
      20. By Probes
      21. By Buffers
      22. By Antibodies
      23. By Other Reagents
    4. North America Neurodiagnostics Market, by Condition
      1. By Neuro Degenerative Diseases
      2. By Epilepsy
      3. By Stroke
      4. By Headache Disorders
      5. By Sleep Disorders
      6. By Other Diseases
    5. North America Neurodiagnostics Market, by End User
      1. By Hospitals and Surgery Centers
      2. By Neurology Centers
      3. By Ambulatory Care Centers
      4. By Diagnostic Laboratories & Imaging Centers
      5. By Research Laboratories & Academic Institutes
    6. North America Neurodiagnostics Market, by Country
      1. U.S.
        1. U.S. Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. U.S. Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. U.S. Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      2. Canada
        1. Canada Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Canada Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Canada Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      3. Mexico
        1. Mexico Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Mexico Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Mexico Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
  5. Europe Neurodiagnostics Market - Segment Analysis
    1. Overview
    2. Europe Neurodiagnostics Market, 2016 - 2028 (USD Million)
    3. Europe Neurodiagnostics Market, by Product
      1. By Diagnostic and Imaging Systems
      2. By Electroencephalogram (EEG) Systems
      3. By Electromyography (EMG) Products
      4. By Magnetic Resonance Imaging (MRI) Systems
      5. By Ultrasound Imaging Systems
      6. By Computed Tomography (Ct) Scanner
      7. By Magnetoencephalogram (Meg) System
      8. By Position Emission Tomography (Pet) System
      9. By Angiography System
      10. By Other Systems
      11. By Clinical Testing Instruments
      12. By PCR
      13. By Next-Generation Sequencing (NGS)
      14. By Sanger Sequencing
      15. By Other Clinical Diagnostic Products
      16. By Reagents & Consumables
      17. By Media and Serra
      18. By Solvents
      19. By Enzymes, Protein & Peptides
      20. By Probes
      21. By Buffers
      22. By Antibodies
      23. By Other Reagents
    4. Europe Neurodiagnostics Market, by Condition
      1. By Neuro Degenerative Diseases
      2. By Epilepsy
      3. By Stroke
      4. By Headache Disorders
      5. By Sleep Disorders
      6. By Other Diseases
    5. Europe Neurodiagnostics Market, by End User
      1. By Hospitals and Surgery Centers
      2. By Neurology Centers
      3. By Ambulatory Care Centers
      4. By Diagnostic Laboratories & Imaging Centers
      5. By Research Laboratories & Academic Institutes
    6. Europe Neurodiagnostics Market, by Country
      1. Germany
        1. Germany Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Germany Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Germany Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      2. UK
        1. UK Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. UK Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. UK Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      3. France
        1. France Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. France Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. France Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      4. Spain
        1. Spain Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Spain Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Spain Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      5. Italy
        1. Italy Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Italy Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Italy Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      6. BENELUX
        1. BENELUX Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. BENELUX Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. BENELUX Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      7. Rest of Europe
        1. Rest Of Europe Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Rest Of Europe Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Rest Of Europe Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
  6. Asia Pacific Neurodiagnostics Market - Segment Analysis
    1. Overview
    2. Asia Pacific Neurodiagnostics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Neurodiagnostics Market, by Product
      1. By Diagnostic and Imaging Systems
      2. By Electroencephalogram (EEG) Systems
      3. By Electromyography (EMG) Products
      4. By Magnetic Resonance Imaging (MRI) Systems
      5. By Ultrasound Imaging Systems
      6. By Computed Tomography (Ct) Scanner
      7. By Magnetoencephalogram (Meg) System
      8. By Position Emission Tomography (Pet) System
      9. By Angiography System
      10. By Other Systems
      11. By Clinical Testing Instruments
      12. By PCR
      13. By Next-Generation Sequencing (NGS)
      14. By Sanger Sequencing
      15. By Other Clinical Diagnostic Products
      16. By Reagents & Consumables
      17. By Media and Serra
      18. By Solvents
      19. By Enzymes, Protein & Peptides
      20. By Probes
      21. By Buffers
      22. By Antibodies
      23. By Other Reagents
    4. Asia Pacific Neurodiagnostics Market, by Condition
      1. By Neuro Degenerative Diseases
      2. By Epilepsy
      3. By Stroke
      4. By Headache Disorders
      5. By Sleep Disorders
      6. By Other Diseases
    5. Asia Pacific Neurodiagnostics Market, by End User
      1. By Hospitals and Surgery Centers
      2. By Neurology Centers
      3. By Ambulatory Care Centers
      4. By Diagnostic Laboratories & Imaging Centers
      5. By Research Laboratories & Academic Institutes
    6. Asia Pacific Neurodiagnostics Market, by Country
      1. China
        1. China Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. China Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. China Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      2. Japan
        1. Japan Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Japan Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Japan Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      3. India
        1. India Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. India Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. India Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      4. South Korea
        1. South Korea Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. South Korea Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. South Korea Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      5. South East Asia
        1. South East Asia Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. South East Asia Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. South East Asia Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Rest of Asia Pacific Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Rest of Asia Pacific Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
  7. Latin America Neurodiagnostics Market - Segment Analysis
    1. Overview
    2. Latin America Neurodiagnostics Market, 2016 - 2028 (USD Million)
    3. Latin America Neurodiagnostics Market, by Product
      1. By Diagnostic and Imaging Systems
      2. By Electroencephalogram (EEG) Systems
      3. By Electromyography (EMG) Products
      4. By Magnetic Resonance Imaging (MRI) Systems
      5. By Ultrasound Imaging Systems
      6. By Computed Tomography (Ct) Scanner
      7. By Magnetoencephalogram (Meg) System
      8. By Position Emission Tomography (Pet) System
      9. By Angiography System
      10. By Other Systems
      11. By Clinical Testing Instruments
      12. By PCR
      13. By Next-Generation Sequencing (NGS)
      14. By Sanger Sequencing
      15. By Other Clinical Diagnostic Products
      16. By Reagents & Consumables
      17. By Media and Serra
      18. By Solvents
      19. By Enzymes, Protein & Peptides
      20. By Probes
      21. By Buffers
      22. By Antibodies
      23. By Other Reagents
    4. Latin America Neurodiagnostics Market, by Condition
      1. By Neuro Degenerative Diseases
      2. By Epilepsy
      3. By Stroke
      4. By Headache Disorders
      5. By Sleep Disorders
      6. By Other Diseases
    5. Latin America Neurodiagnostics Market, by End User
      1. By Hospitals and Surgery Centers
      2. By Neurology Centers
      3. By Ambulatory Care Centers
      4. By Diagnostic Laboratories & Imaging Centers
      5. By Research Laboratories & Academic Institutes
    6. Latin America Neurodiagnostics Market, by Country
      1. Brazil
        1. Brazil Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Brazil Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Brazil Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      2. Argentina
        1. Argentina Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Argentina Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Argentina Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      3. Rest of Latin America
        1. Rest of Latin America Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Rest of Latin America Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Rest of Latin America Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
  8. Middle East & Africa Neurodiagnostics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Neurodiagnostics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Neurodiagnostics Market, by Product
      1. By Diagnostic and Imaging Systems
      2. By Electroencephalogram (EEG) Systems
      3. By Electromyography (EMG) Products
      4. By Magnetic Resonance Imaging (MRI) Systems
      5. By Ultrasound Imaging Systems
      6. By Computed Tomography (Ct) Scanner
      7. By Magnetoencephalogram (Meg) System
      8. By Position Emission Tomography (Pet) System
      9. By Angiography System
      10. By Other Systems
      11. By Clinical Testing Instruments
      12. By PCR
      13. By Next-Generation Sequencing (NGS)
      14. By Sanger Sequencing
      15. By Other Clinical Diagnostic Products
      16. By Reagents & Consumables
      17. By Media and Serra
      18. By Solvents
      19. By Enzymes, Protein & Peptides
      20. By Probes
      21. By Buffers
      22. By Antibodies
      23. By Other Reagents
    4. Middle East & Africa Neurodiagnostics Market, by Condition
      1. By Neuro Degenerative Diseases
      2. By Epilepsy
      3. By Stroke
      4. By Headache Disorders
      5. By Sleep Disorders
      6. By Other Diseases
    5. Middle East & Africa Neurodiagnostics Market, by End User
      1. By Hospitals and Surgery Centers
      2. By Neurology Centers
      3. By Ambulatory Care Centers
      4. By Diagnostic Laboratories & Imaging Centers
      5. By Research Laboratories & Academic Institutes
    6. Middle East & Africa Neurodiagnostics Market, by Country
      1. GCC Countries
        1. GCC Countries Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. GCC Countries Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. GCC Countries Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      2. South Africa
        1. South Africa Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. South Africa Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. South Africa Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Neurodiagnostics Market, By Product
          1. By Diagnostic and Imaging Systems
          2. By Electroencephalogram (EEG) Systems
          3. By Electromyography (EMG) Products
          4. By Magnetic Resonance Imaging (MRI) Systems
          5. By Ultrasound Imaging Systems
          6. By Computed Tomography (Ct) Scanner
          7. By Magnetoencephalogram (Meg) System
          8. By Position Emission Tomography (Pet) System
          9. By Angiography System
          10. By Other Systems
          11. By Clinical Testing Instruments
          12. By PCR
          13. By Next-Generation Sequencing (NGS)
          14. By Sanger Sequencing
          15. By Other Clinical Diagnostic Products
          16. By Reagents & Consumables
          17. By Media and Serra
          18. By Solvents
          19. By Enzymes, Protein & Peptides
          20. By Probes
          21. By Buffers
          22. By Antibodies
          23. By Other Reagents
        2. Rest of Middle East & Africa Neurodiagnostics Market, By Condition
          1. By Neuro Degenerative Diseases
          2. By Epilepsy
          3. By Stroke
          4. By Headache Disorders
          5. By Sleep Disorders
          6. By Other Diseases
        3. Rest of Middle East & Africa Neurodiagnostics Market, By End User
          1. By Hospitals and Surgery Centers
          2. By Neurology Centers
          3. By Ambulatory Care Centers
          4. By Diagnostic Laboratories & Imaging Centers
          5. By Research Laboratories & Academic Institutes
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. GE Healthcare (US)
    2. Siemens Healthiness (Germany)
    3. Philips Healthcare (Netherlands)
    4. Canon Inc. (Japan)
    5. Hitachi Ltd. (Japan)
    6. Lifelines Neuro Company
    7. LLC (US)
    8. Natus Medical Incorporated (US)
    9. Hoffman-La Roche AG (Switzerland)
    10. FUJIFILM Holdings Corporation (Japan)
    11. Mitsar Co. Ltd. (Russia)
    12. Advanced Brain Monitoring (US)
    13. Thermo Fisher Scientific Inc. (US)
    14. Bio-Rad Laboratories (US)
    15. QIAGEN N.V. (Netherlands)
    16. and Nihon Kohden Corporation (Japan)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question

  • The global Neurodiagnostics valued at USD XX Billion in 2024 and is expected to reach USD XX Billion in 2034 growing at a CAGR of 7.4%.

  • The prominent players in the market are GE Healthcare (US), Siemens Healthiness (Germany), Philips Healthcare (Netherlands), Canon, Inc. (Japan), Hitachi, Ltd. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), and Nihon Kohden Corporation (Japan).

  • The market is project to grow at a CAGR of 7.4% between 2025 and 2034.

  • The driving factors of the Neurodiagnostics include

  • XX was the leading regional segment of the Neurodiagnostics in 2024.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy